 Aldeyra Therapeutics, Inc. NASDAQ:ALDX Q2 2022 Earnings Conference Call August 5, 2022 8:00 AM ET Company Participants Bruce Greenberg - Interim Chief Financial Officer Todd Brady - President Chief Executive Officer Conference Call Participants Catherine Novack - Jones Research Yigal Nochomovitz - Citigroup Kelly Shi - Jefferies Tom Shrader - BTIG Justin Kim - Oppenheimer Co. Yale Jen - Laidlaw Company Operator Ladies and gentlemen, thank you for standing by and welcome to the Aldeyra Therapeutics Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. 